Patience is key!
$ChemoCentryx (CCXI.US)$
ChemoCentryx, Inc.'s (NASDAQ:CCXI) avacopan was the only new molecular entity approved during the month. NMEs are new drug products containing an active ingredient that is marketed for the first time in the U.S. Avacopan, which is to go by the brand name Tavneos, has been approved for treating small blood vessel damage.
It’s all good. let’s go!
ChemoCentryx, Inc.'s (NASDAQ:CCXI) avacopan was the only new molecular entity approved during the month. NMEs are new drug products containing an active ingredient that is marketed for the first time in the U.S. Avacopan, which is to go by the brand name Tavneos, has been approved for treating small blood vessel damage.
It’s all good. let’s go!
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment
